6/29/2007 | SS | Inverness completes acquisition of Biosite
|
6/26/2007 | SS | Market Commentary: Huntsman pressures Lyondell, lifts KMG; Ventana pushes Cepheid; BCE off; Vonage up
|
6/26/2007 | SS | Inverness completes tender offer for Biosite, subsequent offer begins
|
6/19/2007 | SS | Gamco, Gabelli investors add to shares of Biosite
|
6/11/2007 | SS | Gamco, Gabelli up ownership of Biosite to 11.87%
|
6/7/2007 | SS | Inverness Medical, Biosite merger clears waiting period hurdle
|
6/5/2007 | SS | Gamco, Gabelli up stake in Biosite to 10.86%
|
5/23/2007 | SS | Gabelli, Gamco continue to increase stake in Biosite
|
5/17/2007 | SS | Inverness to acquire Biosite for $92.50 per share in cash tender offer
|
5/16/2007 | SS | Gamco, Gabelli increase stake in Biosite to 7.69%
|
5/15/2007 | SS | Biosite: Latest offer from Inverness superior, Beckman Coulter will not go higher than $90 per share
|
5/15/2007 | SS | Market Commentary: Dow Jones better, Reuters rises; SunTrust lower; 21st Century up; Ingersoll-Rand gains; Biosite off
|
5/10/2007 | SS | Market Commentary: Magna rises; Hillenbrand split cheered; Griffon seen breaking up; Back Yard Burgers bounces
|
5/10/2007 | SS | Biosite says Inverness' latest proposal could be superior to Beckman Coulter deal
|
5/9/2007 | SS | Inverness raises offer for Biosite to $92.50
|
5/2/2007 | CV | Market Commentary: Beckman Coulter slips on raised bid; Dune gains on debut; Pennsylvania, Epicor, Sinclair quiet in gray
|
5/2/2007 | SS | Beckman Coulter amends Biosite agreement; on par with Inverness Medical offer
|
5/2/2007 | SS | Market Commentary: Cablevision, Bisys gain on buyout offers; Universal eases on uncertainty; Beckman drops on costlier bid
|
4/26/2007 | SS | Biosite to move forward with superior proposal from Inverness; Beckman-Coulter can counter
|
4/26/2007 | SS | Market Commentary: Nacco oscillates; Wendy's gains; Applebee's rises; Biosite bows; Harman up; new Delta slow, low
|
4/20/2007 | SS | Biosite to evaluate revised financing commitment letters from Inverness; Beckman Coulter deal continues
|
4/20/2007 | SS | Market Commentary: Clear Channel off; H&R Block up; Aeroflex rises; Genesco, Foot Locker gain; SLM slides
|
4/18/2007 | SS | Biosite to review revisions from Inverness Medical as Beckman Coulter tender offer continues
|
4/17/2007 | SS | Waiting period expires in Beckman Coulter's acquisition of Biosite; transaction slated to close in May
|
4/10/2007 | SS | Biosite to enter discussions with Inverness Medical; Beckman Coulter tender offer continues
|
4/10/2007 | SS | Market Commentary: United Rentals driven up; Winn-Dixie gains; Ryerson rises; FBR higher as subprime group slides
|
4/9/2007 | SS | Inverness Medical: Biosite fails to respond to $90-per-share acquisition proposal
|
4/9/2007 | SS | Market Commentary: Mirant boosts power producers; Dow Chemical, Devon higher; Herbalife slides; Affordable up
|
4/5/2007 | SS | Market Commentary: Biosite boosted by rival bid; DaimlerChrysler driven up; Conseco climbs; Calpine rises
|
4/5/2007 | SS | Biosite receives unsolicited offer from Inverness Medical as Beckman Coulter deal moves forward
|
3/26/2007 | SS | Beckman Coulter to acquire Biosite in $85-per-share tender offer
|
3/26/2007 | SS | Market Commentary: Biosite buyout lifts diagnostics firms; Rotech rises; Tribune up; Riviera gains; LSI, Agere slump
|
11/15/2006 | BT | Biosite determines main focus areas for resuming historical growth rates in 2007
|
10/26/2006 | BT | Biosite's quarterly revenues up 7% at $74.6 million
|
8/23/2006 | BT | Biosite, Geneva hospital to collaborate on kidney injury research
|
7/27/2006 | BT | Biosite at sector perform by RBC
|
6/21/2006 | BT | Biosite plans diagnostic tests in six new areas
|
5/17/2006 | BT | Biosite to withdraw Triage Stroke Panel PMA
|
4/4/2006 | BT | Biosite, Oxford Genome Sciences to collaborate on diagnostic product for colorectal cancer
|
3/20/2006 | BT | Eli Lilly, Biosite team up on clinical trial using Xigris therapy
|
3/20/2006 | BT | Market Commentary: Boston Life Sciences' stock up as phase 3 trial ends early; BioMarin's stock dips on follow-on stock deal
|
10/26/2005 | BT | Market Commentary: NxStage talk sweetened; Predix pulls IPO; Biosite plunges; CV Therapeutics dives; Idenix rises
|